Amphastar Pharma Stock (NASDAQ: AMPH) stock price, news, charts, stock research, profile.
Open | $43.760 |
Close | - |
Volume / Avg. | 134.815K / 485.251K |
Day Range | 43.760 - 44.830 |
52 Wk Range | 35.620 - 67.660 |
Market Cap | $2.093B |
P/E Ratio | 16.727 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 11.81% |
Days to Cover | 9.77 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Amphastar Pharma (NASDAQ: AMPH) through any online brokerage.
Other companies in Amphastar Pharma’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Neumora Therapeutics (NASDAQ:NMRA), ANI Pharmaceuticals (NASDAQ:ANIP) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Amphastar Pharma (NASDAQ: AMPH) was reported by JP Morgan on Tuesday, March 5, 2024. The analyst firm set a price target for 60.00 expecting AMPH to rise to within 12 months (a possible 37.87% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Amphastar Pharma (NASDAQ: AMPH) is $43.52 last updated March 27, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Amphastar Pharma.
Amphastar Pharma’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Amphastar Pharma.
Amphastar Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.